SciClone Pharmaceuticals International (Cayman) Development Limited
1 clinical trials · Sponsor
◉ Watch SciClone Pharmaceuticals International (Cayman) Development Limited
| Record | Firm | Date |
|---|---|---|
| An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study (NCT02884479) | SciClone Pharmaceuticals International (Cayman) Development Limited | 2016-08-01 |
Track SciClone Pharmaceuticals International (Cayman) Development Limited automatically
Every clearance here is in the API, with alerts when new ones post.